Next Article in Journal
Probiotics and Postbiotics as Substitutes of Antibiotics in Farm Animals: A Review
Next Article in Special Issue
Minireview: Peripheral Nesfatin-1 in Regulation of the Gut Activity—15 Years since the Discovery
Previous Article in Journal
What Do They Know? Comparing Public Knowledge and Opinions about Rodent Management to the Expectations of Pest Controllers
Previous Article in Special Issue
Field-Emission Scanning Electron Microscope as a Tool for Large-Area and Large-Volume Ultrastructural Studies
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Improvement of the Adaptation Process of Tocopherol and Acetylsalicylic Acid in Offspring of Mothers Exposed to TCDD

1
Department of Pediatric Dentistry and Preclinical Dentistry, Faculty of Dentistry, Wroclaw Medical University, Krakowska 26, 50-425 Wroclaw, Poland
2
Department of Histology and Embryology, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, Norwida 25, 50-375 Wroclaw, Poland
3
Department of Basic Sciences, Faculty of Health Sciences, Wroclaw Medical University, Grunwaldzka 2, 50-368 Wroclaw, Poland
4
Department of Laboratory Diagnostics, 4th Military Hospital, Weigla 5, 50-981 Wroclaw, Poland
5
Military Center for Preventive Medicine, Slezna 158, 50-984 Wroclaw, Poland
6
Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla 12, 53-114 Wroclaw, Poland
*
Authors to whom correspondence should be addressed.
Animals 2021, 11(12), 3430; https://doi.org/10.3390/ani11123430
Submission received: 30 October 2021 / Revised: 26 November 2021 / Accepted: 28 November 2021 / Published: 1 December 2021
(This article belongs to the Special Issue Microscopic Structure Research in Animals)

Abstract

:

Simple Summary

Dioxins are proinflammatory factors that may be transferred to offspring through the placenta during pregnancy. α-tocopherol and acetylsalicylic acid are popular agents that limit the spread of inflammation. A histopathological and biochemical analysis was performed to reveal possible changes in liver and blood plasma in response to dioxins, α-tocopherol, and acetylsalicylic acid. The conducted research demonstrated the presence of negative effects on the liver morphology and blood plasma proteins of offspring, due to dioxins that were derived from the mother. However, the use of both drugs can significantly reduce the negative effects on offspring whose mothers have been treated with dioxins.

Abstract

Dioxins are chemical compounds that may cause an inflammatory reaction. During dioxin-induced inflammation, generated reactive oxygen species lead to morphological changes in various tissues and in biochemical parameters. The aim of this study was to demonstrate the changes in the livers of rats whose mothers were exposed to dioxins and the protective role of α-tocopherol and acetylsalicylic acid in liver inflammation. The study material consisted of Buffalo rats who were the offspring of females treated with dioxin, dioxin + α-tocopherol, or dioxin + acetylsalicylic acid. Livers and blood samples were taken from the rats’ offspring, and then histopathological and biochemical analyses were performed. The histopathological analysis showed that the changes observed in the livers of neonates were the result of the dioxins derived from their mother. The biochemical analysis showed that the morphological changes in the liver affected its function, which manifested in a higher total protein concentration in the dioxin-treated group, and that the creatinine level in this group was significantly higher than that in the other groups. This effect was reduced by the protective role of α-tocopherol and acetylsalicylic acid. Based on these results, we came to the conclusion that dioxins significantly affect the structure of the liver, which negatively affects its function, mainly in the scope of the metabolism of plasma proteins and hepatic enzymes.

1. Introduction

The liver plays a significant role in inflammatory response, directly affecting the synthesis of acute-phase proteins and the transformation of steroid hormones such as cortisol, estrogens, and testosterone [1,2,3]. It has been proven that there are many factors that affect the ultrastructure of hepatic cells, causing disorders of their secretory function which in turn affects the concentration of acute-phase proteins and the electrophoretic distribution of plasma proteins. Our own studies have shown the significant effect that mechlorethamine and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) have on hepatic metabolism [4,5,6]. In vitro studies have shown that these compounds interfere with the enzyme kinetics of cathepsin b, as well as having the ability to penetrate into lysosomes [7]. The negative effects of dioxins on hepatic metabolism were manifested by the increased frequency and severity of Disseminated Intravascular Coagulation (DIC) in induced pleurisy [8]. It was demonstrated that the dioxins had multiple proinflammatory influences on the organism that consisted of generating free radicals and reactive oxygen species (ROS) through dechlorination, hydroxylation, and epoxidation [9,10]. The negative effects of dioxins on the body were also manifested by the stimulation of cyclooxygenase-2 (COX-2), as well as the induction of Cytochrome P450, family 1, subfamily A, and polypeptide 1 (CYP1A1) synthesis, contributing to increased hydrolase activity, which is responsible for the decomposition of dioxins [11]. It has been shown that the generation of ROS results from the decomposition of dioxins by the enzyme CYP1A1. The mechanism of this process is based on the attachment of the dioxins to an aryl hydrocarbon receptor (AhR) in the hepatocyte cytosol, which leads to the expression of the cyp1a1 gene and consequently to dechlorination, epoxidation, and hydroxylation [12,13,14]. In response to those processes, there are metabolic disturbances in the liver manifested by hypercholesterolemia, which is associated with increased aspartate transaminase (AST) and alanine transaminase (ALT) levels as well as decreased concentrations of fibrinogen, albumins, and globulins [4,15]. The indirect effect of liver metabolic disorders is manifested in the abnormal degradation of steroid hormones, such as estrogens, testosterone, and cortisol, which are associated with cholesterol metabolism [4,6,16].
Kloser et al. [17] proved that α-tocopherol, in addition to overcoming oxidative stress related to the generation of ROS by dioxins, possesses the blocking properties of an aryl hydrocarbon receptor. Previous studies have shown that when high doses of tocopherol are used in dioxin-contaminated animals, there is a decline in the concentration of diagnostic markers of inflammation and in the results of liver function tests [9,10,18,19]. In addition, it was found that acetylsalicylic acid (ASA) significantly reduces the amount of TCDD binding to cytosolic AhR, as well as potentially blocking the signal transduction initiated by exposure to the dioxin [11,20,21,22]. Studies in type 1-like diabetic rats have indicated that the combination of acetylsalicylic acid and α-tocopherol leads to beneficial changes that could help to protect tissues from thrombotic and ischemic phenomena [23].
A number of our own studies in rats, as well as the observations of other authors [24], have shown that the effects of dioxins are associated with the development of hormonal imbalances, including sex hormones, which affects reproductive functions [25,26,27].
The liver is one of the major organs that is exposed to TCDD due to the high level of metabolism and the immediate proximity of dioxin-accumulating adipose tissue. TCDD and related compounds produce hepatomegaly in all species, even at low doses. Enlarged livers are caused by hyperplasia and the hypertrophy of parenchymal cells, and more specifically by a proliferation of the smooth endoplasmic reticulum [28]. The authors’ own studies have reported that 3 weeks after the administration of 5 μg/kg BW (body weight) of TCDD, macroscopic and histopathological lesions in hepatocytes, manifested by steatosis, were observed in rats [4].
Dioxins have lipophilic properties; hence, they pass from the lipid fraction of plasma to the adipose tissue and liver, as well as passing in the opposite direction. As a result, these compounds are excreted in milk, as found in Eskimo and Japanese women’s milk and polar bear milk [29,30,31]. The consumption of dioxin-contaminated milk resulted in weakened immunity and the occurrence of hermaphroditism in the offspring of polar bears, as well as in microcephaly in children. Fetal and neonatal exposure to dioxins is connected to two routes of transmission from the mother organism—i.e., through the placenta barrier and through breast milk.
The aim of the presented study was to demonstrate the effects of dioxins that were present in the mother organism on her offspring at subsequent stages of development. Due to the fact that the liver is a key organ involved in inflammatory response, the impact of TCDD was assessed on the basis of morphology and the function of this organ, with the simultaneous evaluation of biochemical parameters.

2. Materials and Methods

2.1. Animals

The study material consisted of rats (Buffalo strain) of both sexes as the offspring of TCDD-treated females. Females were divided into 4 groups, with 6 mothers per group:
control: not treated with any chemicals;
TCDD: a single dose of TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin; Greyhound Chromatography and Allied Chemicals, Birkenhead, UK) at a concentration of 5 mg/mL dissolved in dimethyl sulfoxide (DMSO; Sigma-Aldrich, Poznań, Poland) was administered IM (intra-muscular) at a dose of 5 µg/kg BW;
TCDD and tocopherol (TCDD + E): TCDD in a single dose of 5 µg/kg BW was administered IM and a solution of α-tocopherol acetate (oil solution of the drug prepared individually by Hasco-Lek S.A., Wroclaw, Poland) was administered subdermal once a day for 3 weeks at a dose of 30 mg/kg BW.
TCDD and acetylsalicylic acid (TCDD + ASA): TCDD at a single dose of 5 µg/kg BW was administered IM and a suspension of ASA in a starch solution (acetylsalicylic acid, Bayer, Berlin, Germany) was administered P.O. (per os) once a day for 3 weeks at a dose of 30 mg/kg BW.
The females were given the above-mentioned compounds for 3 weeks, then they were mated, and labor took place between the 6th and 7th week from the beginning of the experiment. The sampling material was taken from the liver of the offspring at random on the first day after birth (6 samples from each group), in the fourth week after birth (6 samples from each group), and in the sixth week after birth (6 samples from each group). Groups were named as shown in Table 1 below. Blood samples were taken randomly from the rats’ offspring in the sixth week after birth (6 samples from each group).

2.2. Histopathological Examination

The liver samples were collected, fixed in 4% buffered formaldehyde (pH 7.4), and routinely processed in paraffin. Sections (6 µm thick) were sliced from each block and stained with hematoxylin and eosin (H&E). The slices were then examined and photographed under a light microscope (Nikon Eclipse 80i; Nikon, Melville, NY, USA) with a video camera.
The severity of the observed pathological changes was estimated using semi-quantitative methods according to the methods found in Klopfleish et al. [32] using our own modifications, where we included additional information. Impaired architectonics, sinusoidal vasodilatation, and hyperemia were evaluated on a 0/1 scale. The hypertrophy of the hepatocytes, multinucleated hepatocytes, hyperchromatic nuclei, foamy cytoplasm, clear or basophilic vacuoles in the hepatocyte cytoplasm, blurred boundaries between hepatocytes, and number of mononuclear cells and eosinophils were evaluated on a scale from 0 to 3 points. The results were summarized for each group and a statistical analysis of the obtained data was performed.

2.3. Biochemical Assays

In the sixth week after birth, blood from the rats was collected into standardized hematological and serological test tubes (Sarstedt, Nümbrecht, Germany) while they were under anesthesia, induced by pentobarbital (30 mg/kg BW) into the peritoneum with the use of a cannula catheter injected into the aorta. The electrophoretic separation of blood proteins was performed on an agarose gel according to the manufacturer’s protocol (Beckman Coulter Polska Sp. z o. o., Warsaw, Poland). The reading and analysis of the results were performed at a wavelength of 600 nm using a DT 93 densitometer (Beckman Coulter Polska Sp. z o. o., Warsaw, Poland), according to the manufacturer’s protocol.
The biochemical analysis of the blood collected from the rats was performed on the RA-1000 analyzer (Technikon S.A., Tournai, Belgium) using dedicated reagents purchased from the same manufacturer. Among the measured parameters were:
Total protein (TP)—concentration measured based on the modified biuret reaction in an alkaline environment [33] at λ = 550 nm. Results are given in g/dL. The total precision of the test is ≤2.1% coefficient of variation (CV) and the sensitivity is 1.0 g/l;
Albumin (Alb)—concentration measured using bromocresol green in an acidic environment [34] and absorbance measured at λ = 600 nm. Results are given in g/dL. The total precision of the test is ≤1.4% CV and the sensitivity is 1.0 g/L;
Urea—concentration measured with the use of urease and glutamate dehydrogenase [35] at λ = 340 nm. Results are given in mg/dL. The total precision of the test is ≤2.8% CV and the sensitivity is 1.1 mmol/L;
Creatinine—measurement based on a modified method with picric acid in an alkaline environment [36], with the absorbance measured at λ = 600 nm. Results are given in mg/dL. The total precision of the test is ≤1.7% CV and the sensitivity is 2 μmol/L;
Aspartate aminotransferase (AST)—measured with the use of a Tris-HCl buffer, with L-aspartate and pyridoxal phosphate, based on the International Federation of Clinical Chemistry Protocol [37]. Results are given in U/L. The total precision of the test is ≤2.0% CV and the sensitivity is 2.0 U/L;
Alanine aminotransferase (ALT)—measured based on the IFCC protocol [37]. Results are given in U/L. The total precision of the test is ≤2.5% CV and the sensitivity is 2.0 U/L;
Gamma-glutamyltransferase (GGT)—measured using an automated Konelab 60i biochemical analyzer (ThermoFisher Scientific, Rochester, NY, USA). GGT concentration was provided in U/L.

2.4. Statistical Analysis

All obtained data were statistically analyzed with the use of the Statistica v. 9.0 software (Tibco Software Inc, Palo Alto, CA, USA). Means with standard deviations (SD), minimum value ranges (Min), and maximum value ranges (Max) were calculated. The distribution of data was tested with the Student’s t-test. An analysis of variance (ANOVA) and Pearson’s correlation coefficients was calculated to verify the variability of the studied characteristics between the groups. In all analyses, a p-value of p < 0.05 was considered statistically significant.

3. Results

3.1. Histopathological Examination

In the group of neonates from the TCDD-treated females, the presence of numerous basophilic vacuoles in the cytoplasm of hepatocytes, the blurring of the intercellular boundaries between hepatocytes, and a disordered liver architecture consisting of the dissociation of hepatocytes were observed (Figure 1). Several liver cells showed a foam structure of the cytoplasm and the hyperchromasia of the nuclei. The presence of single multinucleate cells (polycariocytes) was also observed. In the group of neonates from the TCDD + E-treated females, the predominant symptoms were a very foamy cytoplasm of hepatocytes; the presence of numerous basophilic vacuoles in the cytoplasm; and the occurrence of numerous clusters of white blood cells, mostly eosinophils. The hypertrophy, multinucleation, or hyperchromasia of nuclei were observed in single liver cells.
In the group of 4-week-old rats derived from TCDD-treated mothers, a very foamy cytoplasm with colorless vacuoles, plasmolysis, and hyperchromasia of nuclei were observed in a large number of hepatocytes. In the TCDD + E group, no foamy cytoplasm was observed. An infiltration of white blood cells and single hypertrophic hepatocytes appeared in the preparations. In the TCDD + ASA group, a large number of hepatocytes exhibited a very foamy cytoplasm, as well as plasmolysis and the hyperchromasia of nuclei. Clusters of mononuclear phagocytic cells were also observed, mostly located around the central vein and the hepatic triad. Isolated groups of hypertrophic hepatocytes were also noted.
In the livers of 6-week-old individuals, the hypertrophy of a moderate number of hepatocytes was only observed in the TCDD group. The hyperchromasia of nuclei was observed in all three groups treated with dioxins, but the number of changed cells was highest in the TCDD group, medium in the TCDD + E group, and low in the TCDD + ASA group. Clusters of peripheral blood mononuclear cells (PBMCs) were visible in all groups, but their numbers were higher in TCDD + E and TCDD + ASA, and the latter was accompanied by infiltrations of various cell types in the central vein and the hepatic triad.
The results of the scoring indicate a gradual improvement in hepatic structure in all the experimental groups (Figure 2 and Figure 3). However, in the ASA group, 4-week-old animals showed a moderate acceleration in cell division (multinucleated hepatocytes) and an increased number of macrophages in the liver. We also observed slight edematic changes in the liver, therefore the scoring revealed some negative pictures of the liver. Liver derived from 6-week-old offspring showed an almost normal structure.

3.2. Biochemical Analysis

The results of the biochemical parameters are included in Figure 4. Based on these, the following differences were determined:
GGT levels in the rats in the control group were significantly lower than those in the TCDD group (29.8 vs. 116.0; p = 0.039) and TCDD + ASA group (29.8 vs. 125.0; p = 0.021). Other differences were statistically insignificant (p > 0.05).
Urea levels in the rats in the TCDD + ASA group were significantly lower than those in the rats in the other groups (p < 0.01).
Creatinine levels in the rats in the control group were significantly higher than those in the rats in the other groups (p < 0.01).
ALT levels in the rats in the TCDD + ASA group were significantly lower than those in the rats in the other groups (p < 0.01). Similar correlations were presented in the AST parameter measurement.
Total protein levels in the rats in the TCDD + ASA group were significantly lower than those in the rats in the other groups (p < 0.01). Similar correlations were presented in the results of the measurements of concentrations of the α1, β1 of and γ globulins. The level of β2 globulin in the TCDD + ASA group was significantly lower than that in the TCDD group.

4. Discussion

The changes that were observed in the livers of neonates probably resulted from the dioxins derived from mother through the placenta. Another possible mechanism, in later periods of development, is that nurslings become affected with dioxins through the transfer of dioxins via milk [38]. Previous studies by other authors have shown that dioxins cause morphological changes in the liver. The affected cells show morphological changes, indicating an increase in endoplasmic reticulum. Moreover, the livers of animals that are chronically subjected to chemicals become fatty. Fat-storing vesicles increase in both size and number [39,40]. The livers of TCDD-exposed mice show an infiltration of inflammatory cells. The liver weight increases by 14% in response to TCDD. These results indicate that the TCDD-exposed mice were free from overt abnormalities in the first 4 days, while liver damage became apparent around day 6 and then progressed. Finally, body weight started to decline around day 14, when the liver damage was clearly manifested [41]. In the studies of Ozeki et al. [22], liver histology showed that TCDD treatment induces a local infiltration of inflammatory cells, and a small number of TUNEL-positive hepatocytes (terminal deoxynucleotidyl transferase-mediated dUTP nick-end -positive) were found only in portions of the pericentral and periportal areas, but not in inflamed regions.
In previous studies by the authors, histopathological changes in the livers of rats treated with TCDD (5 μg/kg BW) were observed, which were manifested through the presence of multiple foci of steatotic hepatocytes (degeneration adiposa peripherica), as well as the frequently occurring necrotic foci of these cells. In some animals, a slight hepatic congestion was noted [4,9]. It is significant that indirect effects of dioxins were observed in the offspring of mothers treated with TCDD. In 4-week-old offspring and 6-week-old offspring, morphological changes in the liver were observed, such as foamy cytoplasm with colorless vacuoles as well as the plasmolysis and hyperchromasia of the nuclei.
In the present study, no significant effect of tocopherol was observed on the TCDD-treated mothers in relation to the intensity of histopathological changes in the livers of the neonates. In contrast, a clear impact of tocopherol, manifesting itself as the absence of colorless vacuoles in the cytoplasm of hepatocytes and hepatic cell plasmolysis, was shown in the group of 4-week-old rats as compared to the TCDD group, where these changes were strongly expressed. In the 6-week-old rats, a positive effect of tocopherol and ASA was observed in the absence, or almost complete reduction, of hypertrophic hepatocytes and a visible reduction in the number of cells showing hyperchromasia of the nuclei. This is probably due to the antagonist reaction of the ASA on the aryl hydrocarbon receptor, which is known to induce an inflammation reaction in 2,3,7,8-TCDD-intoxicated organisms [42]. Tocopherol seems to have similar effects, besides its known influence on anti-free radical activity [17].
The previous studies of the authors on the same material have shown that significant changes in the tooth structure during the development of the teeth, as well as in bone mineralization, occurred in all three age groups of rats derived from TCDD-treated mothers [11,25,43].
The studies by Fowler et al. [44] have shown that, after the administration of 5–25 μg/kg BW of dioxins, changes occur in the smooth endoplasmic reticulum of hepatocytes between the sixth and ninth day. These doses of dioxins also contributed to reduced bile secretion and an increased concentration of coproporphyrins [45]. Under the influence of dioxins, rat thymus involution [46], an elevation of corticosteroid levels [47], changes in humoral response, and elevated levels of α- and β-globulins were observed, while delayed immunological reactivity was observed at low doses of TCDD [6,10].
Small changes in the livers of neonates in all groups treated with TCDD may have resulted from the limited metabolic function of this organ during the ontogenic development. During this period of development, toxins are removed from the fetus via the placenta. In the postnatal period, the liver is affected by TCDD from the milk of poisoned mothers and absorbed in the digestive tract of juveniles, which results in pathological changes occurring in 4-week-old and 6-week-old individuals.
The biochemical studies presented in this paper correlate with the described morphological changes in the liver. They indicate that the morphological damage observed mainly in rats whose mothers were treated with TCDD is reflected in biochemical findings. Based on the results, it was found that the level of GGT was statistically significantly higher in the TCDD group and the TCDD + E group compared to the control sample; however, in the TCDD + ASA group the observed increase in this indicator compared to the control group and the significantly lower level than that seen in the TCDD group indicate the protective action of ASA against the TCDD-induced liver damage. A similar correlation of the positive influence of ASA on the changes induced by TCDD can be seen in the results obtained for AST, ALT, urea, and Alb concentration. Morphological lesions were observed in the liver, which resulted in physiological changes that were confirmed by changes in the biochemical and hematological test results [4,6,48,49]. Importantly, a protective effect of vitamin E in rats treated with TCDD and α-tocopherol, which manifested itself in the lack of visible pathological changes in the structure of internal organs and the activity of hepatic enzymes, was also demonstrated [9,10,50].

5. Conclusions

The intoxication of offspring by administering 2,3,7,8-tetrachloro-dibenzo-p-dioxin to pregnant mothers causes changes in both the liver structure and blood plasma. Dioxins significantly affect the structure of the liver, which negatively affects its function, mainly in the scope of the metabolism of plasma proteins and hepatic enzymes. It has been observed that the administration of acetylsalicylic acid to TCDD-treated mothers results in a reduction in these changes in neonates.

Author Contributions

Conceptualization, M.D., J.P.M. and P.K.; Methodology, J.P.M., P.K., J.M. and M.S.; Validation, A.G.; Formal Analysis, J.P.M., P.K., A.L. and M.T.; Investigation, M.D., A.L. and M.T.; Resources, J.P.M., J.M., M.S. and P.K.; Data Curation, M.D., J.P.M., A.L., M.T., J.M., M.S. and P.K; Writing—Original Draft Preparation, M.D., J.P.M. and P.K.; Writing—Review and Editing, A.L. and M.T.; Visualization, J.P.M., A.L., M.T. and P.K.; Supervision, M.D. and A.G.; Project Administration, M.D.; Funding Acquisition, P.K. and A.G. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding. The APC was supported by statutory research and development activity funds assigned to Wroclaw University of Environmental and Life Sciences as well as to Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences.

Institutional Review Board Statement

This study was approved by the Local Ethics Committee for Animal Experiments at the Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences (Permission number: 38/2009).

Informed Consent Statement

Not applicable.

Data Availability Statement

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Acknowledgments

We thank Ireneusz Całkosiński (1951–2017) for the inspiration and his helpful advice and assistance in organizing the welfare of the animals.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Całkosiński, I.; Dobrzyński, M.; Całkosińska, M.; Seweryn, E.; Bronowicka-Szydełko, A.; Dzierzba, K. Characterization of an Inflammatory Response. Postępy Hig. Med. Dośw. 2009, 63, 395–408. [Google Scholar]
  2. Dobrzyński, M.; Kuropka, P.; Leśków, A.; Herman, K.; Tarnowska, M.; Wiglusz, R.J. Co-Expression of the Aryl Hydrocarbon Receptor and Estrogen Receptor in the Developing Teeth of Rat Offspring after Rat Mothers’ Exposure to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin and the Protective Action of α-Tocopherol and Acetylsalicylic Acid. Adv. Clin. Exp. Med. 2019, 28. [Google Scholar] [CrossRef] [PubMed]
  3. Całkosiński, I.; Majda, J.; Terlecki, G.; Gostomska-Pampuch, K.; Małolepsza-Jarmołowska, K.; Sobolewska, S.; Całkosińska, A.; Kumala, A.; Gamian, A. Dynamic Analysis of Changes of Protein Levels and Selected Biochemical Indices in Rat Serum in the Course of Experimental Pleurisy. Inflammation 2016, 39, 1076–1089. [Google Scholar] [CrossRef] [Green Version]
  4. Całkosiński, I.; Stańda, M.; Borodulin-Nadzieja, L.; Wasilewska, U.; Majda, J.; Cegielski, M.; Dzięgiel, P.; Woźniak, W. The Influence of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) on Changes of Parenchymal Organs Structure and Oestradiol and Cholesterol Concentration in Female Rats. Adv. Clin. Exp. Med. 2005, 14, 211–215. [Google Scholar]
  5. Całkosiński, I.; Rosińczuk-Tonderys, J.; Dzierzba, K.; Bronowicka-Szydełko, A.; Seweryn, E.; Majda, J.; Całkosińska, M.; Gamian, A. Estimation of the Action of Three Different Mechlorethamine Doses on Biochemical Parameters during Experimentally Induced Pleuritis in Rats. Pharmacol. Rep. 2011, 63, 501–517. [Google Scholar] [CrossRef]
  6. Całkosiński, I.; Rosińczuk-Tonderys, J.; Bazan, J.; Dzierzba, K.; Całkosińska, M.; Majda, J.; Dobrzyński, M.; Bronowicka-Szydełko, A. The Influence of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) on Hematological Parameters During Experimentally Induced Pleuritis in Rats. Inflammation 2013, 36, 387–404. [Google Scholar] [CrossRef] [Green Version]
  7. Kędzior, M.; Seredyński, R.; Godzik, U.; Tomczyk, D.; Gutowicz, J.; Terlecka, E.; Całkosiński, I.; Terlecki, G. Inhibition of Cathepsin B Activity by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin. Environ. Sci. Pollut. Res. 2015, 22, 733–737. [Google Scholar] [CrossRef]
  8. Calkosinski, I.; Rosinczuk-Tonderys, J.; Dobrzynski, M.; Palka, L.; Bazan, J. Occurrence of Disseminated Intravascular Coagulation in 2,3,7,8-Tetrachlorodibenzo-p-Dioxin-Induced Pneumonia in the Rat. Adv. Exp. Med. Biol. 2013, 788, 283–292. [Google Scholar] [CrossRef] [PubMed]
  9. Całkosiński, I.; Rosińczuk-Tonderys, J.; Szopa, M.; Dobrzyński, M.; Gamian, A. High Doses of Tocopherol in the Prevention and Potentiation of Dioxin in Experimental Inflammation—Potential Application. Postepy Hig. Med. Dosw. 2011, 65, 143–157. [Google Scholar] [CrossRef] [PubMed]
  10. Całkosiński, I.; Rosińczuk-Tonderys, J.; Bronowicka-Szydełko, A.; Dzierzba, K.; Bazan, J.; Dobrzyński, M.; Majda, J.; Gamian, A.; Dobrzyński, M.; Majda, J.; et al. Effect of Tocopherol on Biochemical Blood Parameters in Pleuritis-Induced Rats Treated with 2,3,7,8-Tetrachlorodibenzo-p-Dioxin. Toxicol. Ind. Health 2015, 31, 510–522. [Google Scholar] [CrossRef] [PubMed]
  11. Dobrzyński, M.; Bazan, J.; Gamian, A.; Rosińczuk-Tonderys, J.; Parulska, O.; Całkosiński, I. The Use of Acetylsalicylic Acid and Tocopherol in Protecting Bone against the Effects of Dioxin Contamination. Rocz. Ochr. Środowiska 2014, 16, 300–322. [Google Scholar]
  12. Vondráček, J.; Krčmář, P.; Procházková, J.; Trilecová, L.; Gavelová, M.; Skálová, L.; Szotáková, B.; Bunček, M.; Radilová, H.; Kozubík, A.; et al. The Role of Aryl Hydrocarbon Receptor in Regulation of Enzymes Involved in Metabolic Activation of Polycyclic Aromatic Hydrocarbons in a Model of Rat Liver Progenitor Cells. Chem.-Biol. Interact. 2009, 180, 226–237. [Google Scholar] [CrossRef]
  13. Lim, J.; DeWitt, J.C.; Sanders, R.A.; Watkins, J.B.; Henshel, D.S. Suppression of Endogenous Antioxidant Enzymes by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin–Induced Oxidative Stress in Chicken Liver During Development. Arch. Environ. Contam. Toxicol. 2007, 52, 590–595. [Google Scholar] [CrossRef] [PubMed]
  14. Genter, M.B.; Clay, C.D.; Dalton, T.P.; Dong, H.; Nebert, D.W.; Shertzer, H.G. Comparison of Mouse Hepatic Mitochondrial versus Microsomal Cytochromes P450 Following TCDD Treatment. Biochem. Biophys. Res. Commun. 2006, 342, 1375–1381. [Google Scholar] [CrossRef]
  15. Całkosiński, I.; Rosińczuk-Tonderys, J.; Bazan, J.; Dobrzyński, M.; Bronowicka-Szydełko, A.; Dzierzba, K. The Influence of Dioxin Intoxication on the Human System and Possibilities of Limiting Its Negative Effects on the Environment and Living Organisms. Ann. Agric. Environ. Med. 2014, 21, 518–524. [Google Scholar] [CrossRef]
  16. Różewicz, M.; Bombik, E.; Janocha, A.; Łagowska, K.; Bednarczyk, M. Dioxins—Their Influence on Human Health and the Contamination of Products of Animal Origin. Folia Pomeranae Univ. Technol. Stetin. 2016, 328, 189–202. [Google Scholar] [CrossRef]
  17. Kloser, E.; Böhmdorfer, S.; Brecker, L.; Kählig, H.; Netscher, T.; Mereiter, K.; Rosenau, T. Synthesis of 5-(Fluorophenyl)Tocopherols as Novel Dioxin Receptor Antagonists. Eur. J. Org. Chem. 2011, 2450–2457. [Google Scholar] [CrossRef]
  18. Dobrzyński, M.; Korczyński, M.; Herman, K.; Całkosiński, I. Evaluation of the Protective Effect of Different Doses of Alpha-Tocopherol on Calcium and Magnesium Content in Bone Tissue of Rats Treated with 2,3,7,8-Tetrachlorodibenzo-p-Dioxin. Przemysł Chem. 2016, 1, 155–158. [Google Scholar] [CrossRef]
  19. Kuropka, P.; Dobrzynski, M.; Tarnowska, M.; Styczynska, M.; Dudek, K.; Leskow, A.; Wiglusz, R.J. The Influence of High Doses of A-Tocopherol on the Content of Selected Trace Elements in the Liver of Developing Chicken Embryos in Experimentally Induced 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Intoxication. Acta Biochim. Pol. 2019, 66. [Google Scholar] [CrossRef]
  20. MacDonald, C.J.; Cheng, R.Y.S.; Roberts, D.D.; Wink, D.A.; Yeh, G.C. Modulation of Carcinogen Metabolism by Nitric Oxide-Aspirin 2 Is Associated with Suppression of DNA Damage and DNA Adduct Formation. J. Biol. Chem. 2009, 284, 22099–22107. [Google Scholar] [CrossRef] [Green Version]
  21. Leśków, A.; Tarnowska, M.; Rosińczuk, J.; Dobrzyński, M.; Kaliszewski, K.; Majda, J.; Żybura-Wszol̷a, K.; Sobolewska, S.; Diakowska, D. Xanthohumol Effect on 2,3,7,8-Tetrachlorodibenzo-p-Dioxin-Treated Japanese Quails in Terms of Serum Lipids, Liver Enzymes, Estradiol, and Thyroid Hormones. ACS Omega 2020, 5, 24445–24452. [Google Scholar] [CrossRef] [PubMed]
  22. Ozeki, J.; Uno, S.; Ogura, M.; Choi, M.; Maeda, T.; Sakurai, K.; Matsuo, S.; Amano, S.; Nebert, D.W.; Makishima, M. Aryl Hydrocarbon Receptor Ligand 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Enhances Liver Damage in Bile Duct-Ligated Mice. Toxicology 2011, 280, 10–17. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. González-Correa, J.A.; Arrebola, M.M.; Guerrero, A.; Cañada, M.J.; Muñoz Marín, J.; Sánchez De La Cuesta, F.; De La Cruz, J.P. Antioxidant and Antiplatelet Effects of the Alpha-Tocopherol–Aspirin Combination in Type 1-like Diabetic Rats. Life Sci. 2006, 79, 1405–1412. [Google Scholar] [CrossRef] [PubMed]
  24. Inui, H.; Itoh, T.; Yamamoto, K.; Ikushiro, S.I.; Sakaki, T. Mammalian Cytochrome P450-Dependent Metabolism of Polychlorinated Dibenzo-p-Dioxins and Coplanar Polychlorinated Biphenyls. Int. J. Mol. Sci. 2014, 15, 14044–14057. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Dobrzyński, M.; Kaczmarek, U.; Kuropka, P.; Reichert, P.; Grzech-Leśniak, K.; Całkosiński, I. Tooth Development Disorders in Infants of Rat Dams Exposed to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin and Protective Role of Tocopherol and Acetyl Salicylic Acid. Pol. J. Vet. Sci. 2017, 20, 769–778. [Google Scholar] [CrossRef]
  26. Marinković, N.; Pašalić, D.; Ferenčak, G.; Gršković, B.; Rukavina, A.S. Dioxins and Human Toxicity. Arhiv Za Hig. Rada I Toksikol. 2010, 61, 445–453. [Google Scholar] [CrossRef] [Green Version]
  27. White, S.S.; Birnbaum, L.S. An Overview of the Effects of Dioxins and Dioxin-Like Compounds on Vertebrates, as Documented in Human and Ecological Epidemiology. J. Environ. Sci. Health Part C 2009, 27, 197–211. [Google Scholar] [CrossRef] [Green Version]
  28. Gagliano-Jucá, T.; Tang, E.R.; Bhasin, S.; Pencina, K.M.; Anderson, S.; Jara, H.; Li, Z.; Melamud, K.; Coleman, S.L.; Aakil, A.; et al. Effects of Testosterone Administration (and Its 5-Alpha-Reduction) on Parenchymal Organ Volumes in Healthy Young Men: Findings from a Dose-Response Trial. Andrology 2017, 5, 889–897. [Google Scholar] [CrossRef] [Green Version]
  29. Ae, R.; Nakamura, Y.; Tada, H.; Kono, Y.; Matsui, E.; Itabashi, K.; Ogawa, M.; Sasahara, T.; Matsubara, Y.; Kojo, T.; et al. An 18-Year Follow-up Survey of Dioxin Levels in Human Milk in Japan. J. Epidemiol. 2018, 28, 300–306. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  30. Lehmann, G.M.; Lakind, J.S.; Davis, M.H.; Hines, E.P.; Marchitti, S.A.; Alcala, C.; Lorber, M. Environmental Chemicals in Breast Milk and Formula: Exposure and Risk Assessment Implications. Environ. Health Perspect. 2018, 126. [Google Scholar] [CrossRef]
  31. Fürst, P. Dioxins, Polychlorinated Biphenyls and Other Organohalogen Compounds in Human Milk. Mol. Nutr. Food Res. 2006, 50, 922–933. [Google Scholar] [CrossRef]
  32. Klopfleisch, R. Multiparametric and Semiquantitative Scoring Systems for the Evaluation of Mouse Model Histopathology—A Systematic Review. BMC Vet. Res. 2013, 9, 123. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Skeggs, L.T.; Hochstrasser, H. Multiple automatic sequential analysis. Clin. Chem. 1964, 10, 918–936. [Google Scholar] [CrossRef] [PubMed]
  34. Doumas, B.T.; Watson, W.A.; Biggs, H.G. Albumin Standards and the Measurement of Serum Albumin with Bromcresol Green. Clin. Chim. Acta 1997, 258, 21–30. [Google Scholar] [CrossRef]
  35. Talke, H.; Schubert, G.E. Enzymatic Urea Determination in The Blood and Serum i The Warburg Optical Test. Klin. Wochenschr. 1965, 43, 174–175. [Google Scholar] [CrossRef] [PubMed]
  36. Peake, M.; Whiting, M. Measurement of Serum Creatinine—Current Status and Future Goals. Clin. Biochem. Rev. 2006, 27, 173. [Google Scholar]
  37. Bergmeyer, H.U.; Fyrder, M. IFCC Methods for the Measurement of Catalytic Concentration of Enzymes. Clin. Chem. Lab. Med. 1980, 18, 521–541. [Google Scholar] [CrossRef]
  38. Takeda, T.; Fujii, M.; Izumoto, W.; Hattori, Y.; Matsushita, T.; Yamada, H.; Ishii, Y. Gestational Dioxin Exposure Suppresses Prolactin-Stimulated Nursing in Lactating Dam Rats to Impair Development of Postnatal Offspring. Biochem. Pharmacol. 2020, 178. [Google Scholar] [CrossRef]
  39. Kennedy, G.D.; Nukaya, M.; Moran, S.M.; Glover, E.; Weinberg, S.; Balbo, S.; Hecht, S.S.; Pitot, H.C.; Drinkwater, N.R.; Bradfield, C.A. Liver Tumor Promotion by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Is Dependent on the Aryl Hydrocarbon Receptor and TNF/IL-1 Receptors. Toxicol. Sci. 2014, 140, 135–143. [Google Scholar] [CrossRef] [Green Version]
  40. Duval, C.; Teixeira-Clerc, F.; Leblanc, A.F.; Touch, S.; Emond, C.; Guerre-Millo, M.; Lotersztajn, S.; Barouki, R.; Aggerbeck, M.; Coumoul, X. Chronic Exposure to Low Doses of Dioxin Promotes Liver Fibrosis Development in the C57BL/6J Diet-Induced Obesity Mouse Model. Environ. Health Perspect. 2017, 125, 428–436. [Google Scholar] [CrossRef] [Green Version]
  41. Yoshioka, W.; Higashiyama, W.; Tohyama, C. Involvement of MicroRNAs in Dioxin-Induced Liver Damage in the Mouse. Toxicol. Sci. 2011, 122, 457–465. [Google Scholar] [CrossRef]
  42. MacDonald, C.J.; Ciolino, H.P.; Yeh, G.C. The Drug Salicylamide Is an Antagonist of the Aryl Hydrocarbon Receptor That Inhibits Signal Transduction Induced by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin. Cancer Res. 2004, 64, 429–434. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Dobrzyński, M.; Całkosiński, I.; Przywitowska, I.; Kobierska−Brzoza, J.; Czajczyńska−Waszkiewicz, A.; Sołtan, E.; Parulska, O. The Effects of Dioxins in Environmental Pollution on Development of Teeth Disorders. Pol. J. Environ. Stud. 2009, 18, 319–323. [Google Scholar]
  44. Fowler, B.A.; Lucier, G.W.; Brown, H.W.; McDaniel, O.S. Ultrastructural Changes in Rat Liver Cells Following a Single Oral Dose of TCDD. Environ. Health Perspect. 1973, 5, 141–148. [Google Scholar] [CrossRef]
  45. Kakizuka, S.; Takeda, T.; Komiya, Y.; Koba, A.; Uchi, H.; Yamamoto, M.; Furue, M.; Ishii, Y.; Yamada, H. Dioxin-Produced Alteration in the Profiles of Fecal and Urinary Metabolomes: A Change in Bile Acids and Its Relevance to Toxicity. Biol. Pharm. Bull. 2015, 38, 1484–1495. [Google Scholar] [CrossRef] [Green Version]
  46. Tomita, S.; Jiang, H.-B.; Ueno, T.; Takagi, S.; Tohi, K.; Maekawa, S.-I.; Miyatake, A.; Furukawa, Y.T.; Gonzalez, F.J.; Takeda, J.; et al. T Cell-Specific Disruption of Arylhydrocarbon Receptor Nuclear Translocator (Arnt) Gene Causes Resistance to 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Induced Thymic Involution. J. Immunol. 2003, 171, 4113–4120. [Google Scholar] [CrossRef] [Green Version]
  47. Kido, T.; Van Dao, T.; Ho, M.D.; Dang, N.D.; Pham, N.T.; Okamoto, R.; Pham, T.T.; Maruzeni, S.; Nishijo, M.; Nakagawa, H.; et al. High Cortisol and Cortisone Levels Are Associated with Breast Milk Dioxin Concentrations in Vietnamese Women. Eur. J. Endocrinol. 2014, 170, 131–139. [Google Scholar] [CrossRef] [Green Version]
  48. Hilscherova, K.; Blankenship, A.L.; Nie, M.; Coady, K.K.; Upham, B.L.; Trosko, J.E.; Giesy, J.P. Oxidative Stress in Liver and Brain of the Hatchling Chicken (Gallus domesticus) Following in Ovo Injection with TCDD. Comp. Biochem. Physiol. Part C Toxicol. Pharmacol. 2003, 136, 29–45. [Google Scholar] [CrossRef]
  49. Całkosiński, I.; Dobrzyński, M.; Cegielski, M.; Sieja, A.; Całkosińska, M. The Multifaceted Effect of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) in Organisms, Especially Dentition Changes. Postepy Hig. I Med. Dosw. 2006, 60, 237–240. [Google Scholar]
  50. Gostomska-Pampuch, K.; Ostrowska, A.; Kuropka, P.; Dobrzyński, M.; Ziółkowski, P.; Kowalczyk, A.; Łukaszewicz, E.; Gamian, A.; Całkosiński, I. Protective Effects of Levamisole, Acetylsalicylic Acid, and α-Tocopherol against Dioxin Toxicity Measured as the Expression of AhR and COX-2 in a Chicken Embryo Model. Histochem. Cell Biol. 2017, 147, 523–536. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Histopathological changes in the liver of the progeny of TCDD-treated female rats: CV—central vein; HT—hepatic triad; asterisk—impaired architectonics and hepatocytes with hyperchromatic nuclei; arrowhead—basophilic vacuoles in the cytoplasm of hepatocytes; arrow—infiltration of mononuclear cells. Scale bar (AL) = 100 µm.
Figure 1. Histopathological changes in the liver of the progeny of TCDD-treated female rats: CV—central vein; HT—hepatic triad; asterisk—impaired architectonics and hepatocytes with hyperchromatic nuclei; arrowhead—basophilic vacuoles in the cytoplasm of hepatocytes; arrow—infiltration of mononuclear cells. Scale bar (AL) = 100 µm.
Animals 11 03430 g001
Figure 2. Scoring of histopathological changes in the livers of offspring from TCDD-treated female rats from groups: control, TCDD, TCDD + E, TCDD + ASA (A) on the first day after birth, (B) four weeks after birth, and (C) six weeks after birth. Data are presented as mean ± standard deviation. Statistically significant differences (p < 0.05) are marked as follows: * in comparison to control, # in comparison to TCDD group, ^ in comparison to TCDD+E group.
Figure 2. Scoring of histopathological changes in the livers of offspring from TCDD-treated female rats from groups: control, TCDD, TCDD + E, TCDD + ASA (A) on the first day after birth, (B) four weeks after birth, and (C) six weeks after birth. Data are presented as mean ± standard deviation. Statistically significant differences (p < 0.05) are marked as follows: * in comparison to control, # in comparison to TCDD group, ^ in comparison to TCDD+E group.
Animals 11 03430 g002
Figure 3. Scoring of histopathological changes in the livers of offspring from TCDD-treated female rats and their progress in time (1—first day of birth; 2—fourth week after birth; 3—sixth week after birth) in groups: (A) control, (B) TCDD, (C) TCDD + E, and (D) TCDD + ASA. Data are presented as mean ± standard deviation. Statistically significant differences (p < 0.05) are marked as follows: * in comparison to first day of birth, # in comparison to fourth week after birth.
Figure 3. Scoring of histopathological changes in the livers of offspring from TCDD-treated female rats and their progress in time (1—first day of birth; 2—fourth week after birth; 3—sixth week after birth) in groups: (A) control, (B) TCDD, (C) TCDD + E, and (D) TCDD + ASA. Data are presented as mean ± standard deviation. Statistically significant differences (p < 0.05) are marked as follows: * in comparison to first day of birth, # in comparison to fourth week after birth.
Animals 11 03430 g003
Figure 4. Concentration of selected biochemical markers of liver and kidney function, such as gamma-glutamyltransferase (GGT), aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatinine, urea, total protein (TP), albumin (Alb), globulins (α1, α2, β1, β2, γ) in the blood of rats’ offspring from groups 3C, 3D, 3DE, 3DA. Data are presented as mean ± standard deviation. Statistically significant differences (p < 0.05) are marked as follows: * in comparison to control group, # in comparison to TCDD group, ^ in comparison to TCDD + E group.
Figure 4. Concentration of selected biochemical markers of liver and kidney function, such as gamma-glutamyltransferase (GGT), aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatinine, urea, total protein (TP), albumin (Alb), globulins (α1, α2, β1, β2, γ) in the blood of rats’ offspring from groups 3C, 3D, 3DE, 3DA. Data are presented as mean ± standard deviation. Statistically significant differences (p < 0.05) are marked as follows: * in comparison to control group, # in comparison to TCDD group, ^ in comparison to TCDD + E group.
Animals 11 03430 g004
Table 1. Codes for experimental groups.
Table 1. Codes for experimental groups.
ControlTCDDTCDD + ETCDD + ASA
1st day after birth1C1D1DE1DA
4th week after birth2C2D2DE2DA
6th week after birth3C3D3DE3DA
C—control, D—dioxin, DE—dioxin + E, DA—dioxin + ASA.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Dobrzyński, M.; Madej, J.P.; Leśków, A.; Tarnowska, M.; Majda, J.; Szopa, M.; Gamian, A.; Kuropka, P. The Improvement of the Adaptation Process of Tocopherol and Acetylsalicylic Acid in Offspring of Mothers Exposed to TCDD. Animals 2021, 11, 3430. https://doi.org/10.3390/ani11123430

AMA Style

Dobrzyński M, Madej JP, Leśków A, Tarnowska M, Majda J, Szopa M, Gamian A, Kuropka P. The Improvement of the Adaptation Process of Tocopherol and Acetylsalicylic Acid in Offspring of Mothers Exposed to TCDD. Animals. 2021; 11(12):3430. https://doi.org/10.3390/ani11123430

Chicago/Turabian Style

Dobrzyński, Maciej, Jan P. Madej, Anna Leśków, Małgorzata Tarnowska, Jacek Majda, Monika Szopa, Andrzej Gamian, and Piotr Kuropka. 2021. "The Improvement of the Adaptation Process of Tocopherol and Acetylsalicylic Acid in Offspring of Mothers Exposed to TCDD" Animals 11, no. 12: 3430. https://doi.org/10.3390/ani11123430

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop